Man Xu
Impact in
-
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
Papers in
-
- Signaling Pathways in Disease 3
-
- Cardiac Fibrosis and Remodeling 7
- Co-authors
- Qizhu Tang (13 shared papers)Qingqing Wu (7 shared papers)Wei Deng (6 shared papers)Chun‐Xia Wan (6 shared papers)Di Fan (4 shared papers)Hai‐Ming Wu (3 shared papers)Libo Liu (5 shared papers)Yingying Guo (3 shared papers)
- Journals
- International Journal of Molecular Medicine (2 papers)Frontiers in Genetics (1 paper)Biochemical and Biophysical Research Communications (1 paper)Frontiers in Cardiovascular Medicine (1 paper)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Man Xu
28 papers receiving 745 citations
Peers
Comparison fields: 5 of 89
- Cardiology and Cardiovascular Medicine 146
- Cancer Research 87
- Complementary and alternative medicine 43
- Pharmacology 41
- Geriatrics and Gerontology 15
Countries citing papers authored by Man Xu
This map shows the geographic impact of Man Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Xu more than expected).
Fields of papers citing papers by Man Xu
This network shows the impact of papers produced by Man Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Xu. The network helps show where Man Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Man Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 83 | |
| 2 | 2021 | 76 | |
| 3 | 2019 | 70 | |
| 4 | 2017 | 64 | |
| 5 | 2019 | 51 | |
| 6 | 2018 | 49 | |
| 7 | 2024 | 37 | |
| 8 | 2019 | 36 | |
| 9 | 2019 | 28 | |
| 10 | 2022 | 28 | |
| 11 | 2020 | 25 | |
| 12 | 2017 | 24 | |
| 13 | 2022 | 24 | |
| 14 | 2021 | 24 | |
| 15 | 2020 | 19 | |
| 16 | 2017 | 19 | |
| 17 | Salvianolate inhibits proliferation and endothelin release in cultured rat mesangial cells. | 2001 | 17 |
| 18 | 2020 | 14 | |
| 19 | 2019 | 12 | |
| 20 | 2022 | 10 |
About Man Xu
Man Xu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 31 papers that have together received 752 indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (7 papers), Corneal surgery and disorders (4 papers), Peptidase Inhibition and Analysis (3 papers), Signaling Pathways in Disease (3 papers), Cancer, Lipids, and Metabolism (2 papers), Flavonoids in Medical Research (2 papers), Traditional Chinese Medicine Analysis (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (146 citations), Cancer Research (87 citations), Complementary and alternative medicine (43 citations), Pharmacology (41 citations) and Geriatrics and Gerontology (15 citations). Man Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Qizhu Tang, Qingqing Wu, Wei Deng, Chun‐Xia Wan, Di Fan, Hai‐Ming Wu, Libo Liu, Yingying Guo, Zhen‐Guo Ma and Jun Yang. Their work appears in journals such as International Journal of Molecular Medicine, Frontiers in Genetics, Biochemical and Biophysical Research Communications, Frontiers in Cardiovascular Medicine and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.